Skip to main content
. 2019 Aug 14;9(21):6314–6333. doi: 10.7150/thno.36252

Figure 1.

Figure 1

Schematic of the synthetic procedure of SF@MnO2/ICG/DOX (SMID) nanoparticles as a multifunctional drug delivery platform for in vivo MR/fluorescence imaging-assisted tri-modal therapy of cancer.